Kenji Kanenawa

A local complication-prevention pathway for Impella-supported cardiogenic shock: a single-center experience.

Journal: Critical care (London, England)

Published: June 29, 2026

Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat　- VERIFY-HF Registry.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 29, 2026

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 18, 2026

Impact of public assistance on long-term outcomes after hospitalization for acute heart failure.

Journal: Frontiers in cardiovascular medicine

Published: July 28, 2025

Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes.

Journal: Journal of the American Heart Association

Published: October 22, 2024

The efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure.

Journal: ESC heart failure

Published: July 19, 2024

Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.

Journal: Journal of cardiology

Published: February 05, 2024

Age-Stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan.

Journal: Journal of the American Heart Association

Published: October 18, 2023

IMPELLA® mechanical circulatory support delivery using a VIABAHN VBX-covered stent.

Journal: Cardiovascular intervention and therapeutics

Published: July 09, 2023

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cancer.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 01, 2021

Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial.

Journal: Circulation. Cardiovascular interventions

Published: February 05, 2021

Frailty and Bleeding After Percutaneous Coronary Intervention.

Journal: The American journal of cardiology

Published: December 14, 2020

A local complication-prevention pathway for Impella-supported cardiogenic shock: a single-center experience.

A local complication-prevention pathway for Impella-supported cardiogenic shock: a single-center experience.

Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat - VERIFY-HF Registry.

Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat - VERIFY-HF Registry.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Impact of public assistance on long-term outcomes after hospitalization for acute heart failure.

Impact of public assistance on long-term outcomes after hospitalization for acute heart failure.

Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes.

Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes.

The efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure.

The efficacy and safety of sodium-glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure.

Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.

Prognostic significance of baseline low-density lipoprotein cholesterol in patients undergoing coronary revascularization; a report from the CREDO-Kyoto registry.

Age-Stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan.

Age-Stratified Prevalence and Relative Prognostic Significance of Traditional Atherosclerotic Risk Factors: A Report from the Nationwide Registry of Percutaneous Coronary Interventions in Japan.

IMPELLA® mechanical circulatory support delivery using a VIABAHN VBX-covered stent.

IMPELLA® mechanical circulatory support delivery using a VIABAHN VBX-covered stent.

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cancer.

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cancer.

Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial.

Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial.

Frailty and Bleeding After Percutaneous Coronary Intervention.

Frailty and Bleeding After Percutaneous Coronary Intervention.

Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat　- VERIFY-HF Registry.

Changes in Natriuretic Peptide Levels and Cardiac Structure in Patients Treated With Vericiguat　- VERIFY-HF Registry.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.